Today: 8 March 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Telix stock price slides 8% as investors digest FY25 revenue update and China Illuccix filing

Telix stock price slides 8% as investors digest FY25 revenue update and China Illuccix filing

Telix Pharmaceuticals shares fell 7.7% to A$10.61 at Wednesday’s close after the company reported unaudited FY2025 revenue in line with guidance and noted early momentum for Gozellix. China’s drug regulator accepted the Illuccix application, triggering a formal review. Investors weighed ongoing U.S. regulatory developments and recent clinical trial results.
Adani Power wins key tribunal nod for Rs 4,000 crore Vidarbha plant takeover

Adani Power wins key tribunal nod for Rs 4,000 crore Vidarbha plant takeover

India’s insolvency appellate tribunal approved Adani Power’s Rs 4,000 crore resolution plan for Vidarbha Industries Power, dismissing appeals from Western Coalfields and an employee representative. The tribunal upheld the payout structure but ordered full payment of provident fund and gratuity dues. The decision removes a key obstacle to Adani’s acquisition of the 600 MW Maharashtra plant. Court documents show creditor approval was secured in February 2025.
21 January 2026
BHP share price rebounds after China iron ore talks, potash cost jump rattles investors

BHP share price rebounds after China iron ore talks, potash cost jump rattles investors

BHP shares closed up 1.47% at A$48.48, rebounding after Tuesday’s drop. The company warned of price concessions in ongoing iron ore supply talks with China and raised its Jansen potash project cost estimate to $8.4 billion. Copper prices rose 32% year-on-year, and iron ore edged up 4%. Investors await BHP’s half-year results on Feb. 17.
CSL share price slips after close as RBC upgrade turns focus to Feb. 11 results

CSL share price slips after close as RBC upgrade turns focus to Feb. 11 results

CSL shares closed down 0.33% at A$176.11 on Wednesday, staying well below last year’s highs. RBC Capital upgraded CSL to “Outperform” and raised its price target to A$230, citing valuation upside despite weak U.S. flu vaccine demand. Investors are focused on CSL’s half-year results and interim dividend due Feb. 11. The S&P/ASX 200 slipped 0.37% amid broader market volatility.
Fortescue share price rises as FMG investors eye quarterly report and iron ore jitters

Fortescue share price rises as FMG investors eye quarterly report and iron ore jitters

Fortescue shares rose 1.7% to A$22.64, rebounding ahead of its December production report due Thursday. The ASX 200 slipped 0.4%, but materials gained 2.7% on miner strength. Iron ore futures fell after weak China property data, while a fatal blast at a Chinese steel plant raised supply concerns. BHP agreed to lower some iron ore prices in ongoing talks with China Mineral Resources Group.
Why UMC stock is up 16% today: 8-inch price hike talk meets Taiwan’s CPO buzz

Why UMC stock is up 16% today: 8-inch price hike talk meets Taiwan’s CPO buzz

United Microelectronics Corp shares jumped 16% Tuesday, closing at $10.82 and leading semiconductor gains as U.S. markets fell. Taipei-listed UMC hit the daily limit before settling up 6-7%, fueled by rumors of 8-inch wafer price hikes. Foreign investors remained net buyers, and UMC confirmed its Singapore Fab 12i P3 expansion is moving toward mass production by 2027. Investors await UMC’s earnings report on Jan. 28.
HYMC stock jumps nearly 17% as silver breaks $95 — what’s driving Hycroft Mining today

HYMC stock jumps nearly 17% as silver breaks $95 — what’s driving Hycroft Mining today

Hycroft Mining shares jumped 16.8% to $40.45 Tuesday as gold hit $4,700 an ounce and silver reached $95, both record highs. Canadian investor Eric Sprott exercised over 4.6 million warrants and bought 200,000 shares last week. Hycroft, which owns a large Nevada mine, has no current production and warned it needs more funding to advance development. Trading volume neared 3 million shares by midday.
Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk

Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk

Qiagen shares jumped 15.9% to $55.13 in U.S. trading Tuesday after reports the diagnostics firm is exploring strategic options, including a potential sale, and has hired advisers. Bloomberg said the company’s board is handling new takeover interest, but talks remain preliminary. Qiagen will report fourth-quarter results Feb. 4, with a conference call set for Feb. 5. The company has not commented on the reports.
MARA stock slides as CEO Thiel trust flags share sale while bitcoin dips

MARA stock slides as CEO Thiel trust flags share sale while bitcoin dips

MARA shares fell 5.1% to $10.78 by midday Tuesday after a filing showed CEO Fred Thiel’s trust intends to sell 27,505 shares under Rule 144. Bitcoin dropped 3%, pressuring mining stocks. The planned sale, valued at $297,054, follows similar trust sales in November and December. Traders are watching for a follow-up insider filing and bitcoin’s next move.
AstraZeneca stock price slides as AZN sets Nasdaq exit, NYSE move dates

AstraZeneca stock price slides as AZN sets Nasdaq exit, NYSE move dates

AstraZeneca shares fell 4.4% to $90.23 Tuesday after the company said it will delist its American depositary shares from Nasdaq and move to a direct listing of ordinary shares on the NYSE starting February 2. The switch, set for after markets close January 30, comes as European stocks face pressure from U.S. tariff threats. AstraZeneca’s London shares also dropped 2.6%.
1 184 185 186 187 188 584
Go toTop